ASCO 2025: Zanidatamab plus chemotherapy shows strong first-line efficacy in HER2-positive gastro-oesophageal adenocarcinoma
A phase 2 trial reports high response rates and durable outcomes in treatment-naive patients, presented…
Browsing: Featured
Paediatric investigation study identifies immune drivers of medulloblastoma metastasis using explainable AI
Medulloblastoma, the most common malignant paediatric brain tumour, presents substantial clinical challenges due to its…
AI could help improve early detection of interval breast cancers
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that…
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
New research presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14…
Cancer Council Victoria’s statewide Bowel Screening Campaign results
Analysis undertaken by the Daffodil Centre shows an additional 25,080 Victorians completed and returned a…
Episode 2: No longer invisible. Addressing the unique challenges of metastatic cancer survivorship
Join Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM for Series 2 of Supportive Care Matter. In this episode, Bogda chats to Associate Professor Nic Hart and Dr Andrea Smith about their work advocating for better supportive care for metastatic cancer patients worldwide.
Study finds structural barriers may prevent cancer care for people living with HIV
People living with HIV are less likely to receive potentially lifesaving cancer treatment if they…
SALSA: A new artificial intelligence tool for the automated and precise analysis of liver tumours
Investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Radiomics Group, Spain, led by Raquel…
Lower screening age calls for more tailored bowel cancer surveillance
Australia’s recent move to lower the starting age for bowel (colorectal) cancer screening from 50…
Colon cancer rates are rising among young people – could changes to children’s gut bacteria explain why?
Justin Stebbing, Anglia Ruskin University Alarming trends show that colon or bowel cancer is increasing…